Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

286
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
286
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

179
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
179
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

206
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
206
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

220
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
220
Stimulants01:29

Stimulants

220
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
220
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

158
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
158

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Workload Caused by Prescription Drug Shortages in General Practices in Germany: Results of a Cross-Sectional Study with Medical Assistants].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2026
Same author

Early trends in outpatient addiction care for cannabis use disorder following cannabis legalization in Germany: Evidence from National Monitoring Data.

Addiction (Abingdon, England)·2026
Same author

Supply and demand of medical cannabis in Germany after legalisation: exploring 12 months of data from an online dispensary.

The International journal on drug policy·2026
Same author

Increase in Cannabis-Specific Hospital Admissions After Partial Legalization in Germany: A Nationwide Time-Series Analysis.

Deutsches Arzteblatt international·2026
Same author

Relationships between cannabis use and mental disorders: assessing the coherence of evidence from studies with different methodologies.

The lancet. Psychiatry·2026
Same author

International cannabis policies and their association with cannabis use, cannabis use disorder, and other psychiatric disorders.

The lancet. Psychiatry·2026

相关实验视频

Updated: Jul 11, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.7K

德国的大麻使用情况

Daniel Kotz1, Sabrina Kastaun, Jakob Manthey

  • 1Institute of General Practice (ifam), Addiction Research and Clinical Epidemiology Unit, Centre for Health and Society (chs), Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf; Department of Behavioural Science and Health, University College London, London, UK; Institute of General Practice (ifam), Patient-Physician Communication Research Unit, Centre for Health and Society (chs), Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf; Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf (UKE); Department of Psychiatry, Medical Faculty, University of Leipzig; IFT Institut für Therapieforschung, Center for Mental Health and Addiction Research, Munich; Department of Psychology, Division of Clinical Psychology and Psychological Treatment, Ludwig-Maximilans-Universität München, Munich; Department of Psychiatry and Psychotherapy, Cannabinoid Research Group, University Hospital, LMU Munich, Munich.

Deutsches Arzteblatt international
|November 15, 2023
PubMed
概括

德国 德国 德国 德国

更多相关视频

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

141
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

214

相关实验视频

Last Updated: Jul 11, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.7K
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

141
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

214

科学领域:

  • 公共卫生 公共卫生
  • 药物使用研究研究 药物使用研究
  • 大麻政策 大麻政策 大麻政策

背景情况:

  • 德国正准备将成人娱乐大麻合法化.
  • 关于大麻使用模式的基线数据对于公共卫生规划至关重要.
  • 了解与尼古丁/烟草的共同使用对于减少危害至关重要.

研究的目的:

  • 评估德国过去一年大麻使用率的流行情况.
  • 为了确定大麻管理的首选途径.
  • 检查大麻与尼古丁或烟草制品的共同使用情况.

主要方法:

  • 一项针对9644名年龄在14岁及以上的个人进行的国家调查的分析.
  • 关于过去一年大麻消费的自我报告数据.
  • 评估最喜欢的给药途径 (吸烟,消费等). ) 的情况.

主要成果:

  • 去年大麻使用率为4.6%,较年轻年龄组 (14-24岁) 的使用率更高.
  • 与烟草或没有烟草一起吸食大麻是主要的给药方法 (92.4%).
  • 尼古丁/烟草产品的共同使用者,特别是水管使用者,显示大麻使用率明显更高 (27.0%).

结论:

  • 吸烟仍然是大麻消费的主要方式,特别是在年轻人中.
  • 预防和减少危害的策略对于减轻大麻相关风险至关重要.
  • 需要持续监测,以评估即将在德国合法化大麻的影响.